Ozempic News
Latest articles and news about Ozempic on AXL Media.
Latest Articles
- Experimental Endoscopic Gut Reset Procedure Shows Potential to Prevent Weight Regain After GLP-1 Cessation
Published: Apr 24, 2026
Section: Medical News
A new study presented at Digestive Disease Week 2026 indicates that duodenal mucosal resurfacing (DMR) may prevent the weight rebound commonly seen after stopping GLP-1 medications...
- Endoscopic "gut reset" procedure prevents weight rebound after stopping Ozempic and Wegovy
Published: Apr 23, 2026
Section: Research
A new minimally invasive technique called duodenal mucosal resurfacing (DMR) could solve the "weight regain" paradox for patients discontinuing GLP-1 medications. Clinical trial re...
- GLP-1 Weight Loss Study Reveals Higher Social Stigma and "Shortcut" Biases Against White Women
Published: Apr 18, 2026
Section: Mental Health
A new study from Georgetown University finds that women using GLP-1 medications for weight loss face significantly harsher social judgment than those using traditional diet and exe...
- Clinical Study Warns of Critically Low Protein Intake and Nutritional Risks for GLP-1 Drug Users
Published: Apr 10, 2026
Section: Medical News
A real-world analysis of adults using GLP-1 receptor agonists, such as semaglutide and tirzepatide, has identified a significant risk of nutritional deficiency due to drastically r...
- Food Giants and Restaurants Pivot Menus as GLP-1 Adoption Reshapes American Caloric Consumption Patterns
Published: Apr 2, 2026
Section: Companies & Industry
The rapid rise of GLP-1 weight-loss medications is forcing a structural shift in the food and beverage industry, with one in eight U.S. adults now utilizing these treatments. Major...
- New Study Reveals GLP-1 Weight-Loss Drugs May Slow Wound Healing But Reduce Fluid Build-up After Abdominal Surgery
Published: Mar 27, 2026
Section: Science & Tech
A 10-year retrospective analysis published in Plastic and Reconstructive Surgery® indicates that GLP-1 receptor agonists have a "nuanced" impact on patients undergoing panniculecto...
- Medical Experts Warn GLP-1 Weight Loss Drugs Require Lifestyle Integration to Ensure Long-Term Health Success
Published: Mar 26, 2026
Section: Medical News
As GLP-1 medications like Ozempic surge in popularity, physicians emphasize that appetite suppression alone is insufficient for sustainable health improvements. Clinical reports in...
- Stanford Study Identifies Python Blood Metabolite That Mimics Modern Weight Loss Drugs
Published: Mar 19, 2026
Section: Science & Tech
Researchers at Stanford Medicine and the University of Colorado Boulder have discovered that a metabolite called pTOS, which spikes a thousandfold in pythons after feeding, induces...
- Study Finds Preterm Birth Risk Linked to Underlying Diabetes Rather Than Inadvertent GLP-1 Weight Loss Drug Exposure
Published: Mar 18, 2026
Section: Health
A massive Danish study of over 750,000 pregnancies has determined that while weight-loss drugs like Ozempic are associated with a higher risk of premature birth, the danger appears...
- Cleveland Clinic Study Finds 45% of Patients Maintain Weight Loss One Year After Halting GLP-1 Medications
Published: Mar 14, 2026
Section: Science & Tech
A retrospective analysis of nearly 8,000 adults reveals that discontinuing semaglutide or tirzepatide does not necessarily trigger the drastic weight regain observed in previous cl...
- High-Dose Wegovy Linked to Significantly Higher Risk of Sudden Sight Loss and "Eye Stroke" Compared to Other Semaglutide Medications
Published: Mar 12, 2026
Section: Research
A new analysis of FDA adverse event reports published in the British Journal of Ophthalmology reveals that the weight-loss drug Wegovy is associated with a five-fold higher risk of...
- Wegovy Linked To Higher Risks Of Ischaemic Optic Neuropathy And Sudden Vision Loss Than Other Semaglutide Medications
Published: Mar 11, 2026
Section: Health
A comprehensive analysis published in the British Journal of Ophthalmology suggests that Wegovy, a high-dose semaglutide used for weight loss, carries a significantly higher risk o...